Literature DB >> 16375975

Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides.

Emily Reinke1, Zsuzsa Fabry.   

Abstract

Immune privilege in the central nervous system (CNS) is not maintained by immune ignorance of the CNS, but by CNS control over inflammatory processes. In this review we examine the role neuropeptides play in maintenance of immune privilege in the CNS. Vasoactive intestinal peptide, alpha-melanocyte-stimulating-hormone, neuropeptide Y, and somatostatin are members of an anti-inflammatory repertoire of immune modulators, while substance P acts to break immune privilege and promote inflammation in the CNS. Here we focus both on cellular responses to these neuropeptides and the role these peptides play in immune privilege as it relates to CNS autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375975     DOI: 10.1016/j.imlet.2005.11.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

Review 1.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 2.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

3.  Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.

Authors:  Brian M Janelsins; Alicia R Mathers; Olga A Tkacheva; Geza Erdos; William J Shufesky; Adrian E Morelli; Adriana T Larregina
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

4.  A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages.

Authors:  A Amoruso; C Bardelli; G Gunella; F Ribichini; S Brunelleschi
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

5.  VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.

Authors:  Min Song; Jia-xiang Xiong; Yan-yan Wang; Jun Tang; Bo Zhang; Yun Bai
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

Review 6.  Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.

Authors:  Stefano Morara; Anna Maria Colangelo; Luciano Provini
Journal:  Neural Plast       Date:  2015-07-26       Impact factor: 3.599

Review 7.  Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases.

Authors:  Li Tian; Li Ma; Tiina Kaarela; Zhilin Li
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

8.  Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P.

Authors:  Kendal G Cooper; Robert Zarnowski; Jon P Woods
Journal:  PLoS One       Date:  2009-04-22       Impact factor: 3.240

9.  The detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS.

Authors:  Stefan Schob; Martin Schicht; Saadettin Sel; Dankwart Stiller; Alexander S Kekulé; Alexander Kekulé; Friedrich Paulsen; Erik Maronde; Lars Bräuer
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

10.  Neuronal CD200 Signaling Is Protective in the Acute Phase of Ischemic Stroke.

Authors:  Abdullah Al Mamun; Conelius Ngwa; Shaohua Qi; Pedram Honarpisheh; Saumil Datar; Romana Sharmeen; Yan Xu; Louise D McCullough; Fudong Liu
Journal:  Stroke       Date:  2021-08-06       Impact factor: 10.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.